20 Hrs
Source:
الخليج
FDA approves first narcolepsy treatment
The U.S. Food and Drug Administration has approved the drug "Orexivol" for the treatment of narcolepsy type 1 in adults. It is the first treatment that directly targets the deficiency of orexin signals in the brain. Two clinical studies involving 273 patients showed that the medication improves patients' ability to stay awake and reduces episodes of sudden loss of muscle tone, along with improvements in other symptoms such as sleep paralysis and hallucinations, after 12 weeks of treatment. Its side effects include insomnia, increased urination, and increased saliva production.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)